{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:19:33Z","timestamp":1773155973735,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.nmd.2012.10.014","type":"journal-article","created":{"date-parts":[[2012,11,23]],"date-time":"2012-11-23T20:37:20Z","timestamp":1353703040000},"page":"S203-S207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"S3","title":["Fatigue in immune-mediated neuropathies"],"prefix":"10.1016","volume":"22","author":[{"given":"Ingemar S.J.","family":"Merkies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina G.","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2012.10.014_b0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2012.10.014_b0010","doi-asserted-by":"crossref","unstructured":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society \u2013 First Revision. J Peripher Nerv Syst 2010;15:1\u20139.","DOI":"10.1111\/j.1529-8027.2010.00245.x"},{"key":"10.1016\/j.nmd.2012.10.014_b0015","doi-asserted-by":"crossref","unstructured":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society \u2013 first revision. J Peripher Nerv Syst 2010;15:295\u2013301.","DOI":"10.1111\/j.1529-8027.2010.00290.x"},{"key":"10.1016\/j.nmd.2012.10.014_b0020","doi-asserted-by":"crossref","unstructured":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society \u2013 first revision. J Peripher Nerv Syst 2010;15:185\u201395.","DOI":"10.1111\/j.1529-8027.2010.00278.x"},{"key":"10.1016\/j.nmd.2012.10.014_b0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.59.1.84","article-title":"Quality of life complements traditional outcome measures in immune-mediated polyneuropathies","volume":"59","author":"Merkies","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2012.10.014_b0030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1529-8027.2010.00274.x","article-title":"Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study","volume":"15","author":"Merkies","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nmd.2012.10.014_b0035","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.62.6.637","article-title":"Residual health status after Guillain\u2013Barre syndrome","volume":"62","author":"Bernsen","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2012.10.014_b0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jnnp.74.1.99","article-title":"Connecting impairment, disability, and handicap in immune mediated polyneuropathies","volume":"74","author":"Merkies","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2012.10.014_b0045","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1212\/WNL.53.8.1648","article-title":"Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) group","volume":"53","author":"Merkies","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2012.10.014_b0050","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/jnnp.52.8.940","article-title":"Fatigue syndromes: a comparison of chronic \u201cpostviral\u201d fatigue with neuromuscular and affective disorders","volume":"52","author":"Wessely","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2012.10.014_b0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/j.2048-7940.1995.tb01599.x","article-title":"Understanding and coping with neurological impairment","volume":"20","author":"Gregory","year":"1995","journal-title":"Rehabil Nurs"},{"key":"10.1016\/j.nmd.2012.10.014_b0060","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1007\/s00415-010-5653-x","article-title":"Factors associated with long-term functional outcomes and psychological sequelae in Guillain\u2013Barre syndrome","volume":"257","author":"Khan","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2012.10.014_b0065","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1212\/01.WNL.0000148589.87107.9C","article-title":"Physical training and fatigue, fitness, and quality of life in Guillain\u2013Barre syndrome and CIDP","volume":"63","author":"Garssen","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2012.10.014_b0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1529-8027.2010.00259.x","article-title":"Functioning of patients with multifocal motor neuropathy","volume":"15","author":"Erdmann","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nmd.2012.10.014_b0075","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/mus.21994","article-title":"Sleep hypoventilation syndrome and respiratory failure due to multifocal motor neuropathy with conduction block","volume":"43","author":"Kyriakides","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2012.10.014_b0080","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(04)15794-2","article-title":"Fatigue in neurological disorders","volume":"363","author":"Chaudhuri","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2012.10.014_b0085","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00018-009-0184-2","article-title":"Fatigue in neuromuscular disorders: focus on Guillain\u2013Barre syndrome and Pompe disease","volume":"67","author":"de Vries","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.nmd.2012.10.014_b0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clinph.2006.10.018","article-title":"Experienced and physiological fatigue in neuromuscular disorders","volume":"118","author":"Schillings","year":"2007","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.nmd.2012.10.014_b0095","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2012.10.014_b0100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2012.01.024","article-title":"Occurrence of fatigue over 20 years after recovery from Guillain\u2013Barre syndrome","volume":"316","author":"Drory","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2012.10.014_b0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2012.02.026","article-title":"Residual disability 10 years after falling ill in Guillain\u2013Barre syndrome: a prospective follow-up study","volume":"317","author":"Forsberg","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2012.10.014_b0110","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1468-1331.2009.02906.x","article-title":"What constitutes a \u2018good\u2019 recovery outcome in post-acute Guillain\u2013Barre syndrome? Results of a nationwide survey of post-acute GBS sufferers in the United Kingdom","volume":"17","author":"Davidson","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2012.10.014_b0115","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/mus.21158","article-title":"Fatigue as the presenting symptom of chronic inflammatory demyelinating polyneuropathy","volume":"38","author":"Bissay","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2012.10.014_b0120","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1085-9489.2005.10311.x","article-title":"Fatigue as the main presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy: a study of 11 cases","volume":"10","author":"Boukhris","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nmd.2012.10.014_b0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2340\/16501977-0007","article-title":"Analysing the favourable effects of physical exercise: relationships between physical fitness, fatigue and functioning in Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"39","author":"Bussmann","year":"2007","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.nmd.2012.10.014_b0130","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00415-006-0163-6","article-title":"Residual fatigue is independent of antecedent events and disease severity in Guillain\u2013Barre syndrome","volume":"253","author":"Garssen","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2012.10.014_b0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00415-009-0018-z","article-title":"Fatigue, pain and muscle weakness are frequent after Guillain\u2013Barre syndrome and poliomyelitis","volume":"256","author":"Rekand","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2012.10.014_b0140","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1080\/09638280802306497","article-title":"Disability and health status in patients with chronic inflammatory demyelinating polyneuropathy","volume":"31","author":"Westblad","year":"2009","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.nmd.2012.10.014_b0145","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1212\/WNL.0b013e3181f0738e","article-title":"Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy","volume":"75","author":"Cats","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2012.10.014_b0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-3999(03)00371-4","article-title":"The assessment of fatigue: a practical guide for clinicians and researchers","volume":"56","author":"Dittner","year":"2004","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.nmd.2012.10.014_b0155","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/01.mlr.0000245426.10853.30","article-title":"Classical test theory","volume":"44","author":"DeVellis","year":"2006","journal-title":"Med Care"},{"key":"10.1016\/j.nmd.2012.10.014_b0160","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0895-4356(96)00016-9","article-title":"Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts","volume":"49","author":"Stucki","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.nmd.2012.10.014_b0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/165019701300006542","article-title":"Guidelines to statistical evaluation of data from rating scales and questionnaires","volume":"33","author":"Svensson","year":"2001","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.nmd.2012.10.014_b0170","series-title":"Probabilistic models for some intelligence and attainment tests","author":"Rasch","year":"1960"},{"key":"10.1016\/j.nmd.2012.10.014_b0175","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/art.23108","article-title":"The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper?","volume":"57","author":"Tennant","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nmd.2012.10.014_b0180","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1529-8027.2009.00238.x","article-title":"Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale","volume":"14","author":"van Nes","year":"2009","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nmd.2012.10.014_b0185","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00415-006-0962-9","article-title":"Nerve conduction studies in relation to residual fatigue in Guillain\u2013Barre syndrome","volume":"253","author":"Garssen","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2012.10.014_b0190","series-title":"SF-36\u00ae health survey. Manual and interpretation guide","author":"Ware","year":"2000"},{"key":"10.1016\/j.nmd.2012.10.014_b0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jnnp.2004.046227","article-title":"Amantadine for treatment of fatigue in Guillain\u2013Barre syndrome: a randomised, double blind, placebo controlled, crossover trial","volume":"77","author":"Garssen","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2012.10.014_b0200","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1212\/WNL.45.11.1956","article-title":"Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo","volume":"45","author":"Krupp","year":"1995","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nmd.2012.10.014_b0230","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/acr.21647","article-title":"Factors associated with fatigue in early arthritis: results from the ESPOIR cohort","volume":"64","author":"Rat","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.nmd.2012.10.014_b0210","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0961203312436863","article-title":"What do we know about self-reported fatigue in systemic lupus erythematosus?","volume":"21","author":"Cleanthous","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.nmd.2012.10.014_b0215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2036.2011.04914.x","article-title":"Fatigue in out-patients with inflammatory bowel disease is common and multifactorial","volume":"35","author":"Bager","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nmd.2012.10.014_b0220","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/bjc.1993.319","article-title":"Fatigue in cancer patients","volume":"68","author":"Smets","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nmd.2012.10.014_b0225","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jns.2011.08.002","article-title":"Fatigue among stroke patients on long-term follow-up. The Bergen stroke study","volume":"312","author":"Naess","year":"2012","journal-title":"J Neurol Sci"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896612006232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896612006232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:00:50Z","timestamp":1760774450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896612006232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":45,"alternative-id":["S0960896612006232"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2012.10.014","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatigue in immune-mediated neuropathies","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2012.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}